Paper · 42758366
An Accessible Approach to Molecular and Biomarker Testing for Risk Stratification in Oral Cavity Squamous Cell Carcinoma.
Afkhami M and 14 others. Head Neck Pathol, 2026. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. An Accessible Approach to Molecular and Biomarker Testing for Risk Stratification in Oral Cavity Squamous Cell Carcinoma. Papers, record 42758366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42758366
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- An Accessible Approach to Molecular and Biomarker Testing for Risk Stratification in Oral Cavity Squamous Cell Carcinoma.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers, Tumor | Major topic |
| Mouth Neoplasms | Major topic |
| Squamous Cell Carcinoma of Head and Neck | Major topic |
| Humans | |
| Female | |
| Aged, 80 and over | |
| Adult | |
| Middle Aged | |
| Aged | |
| Male | |
| Young Adult | |
| High-Throughput Nucleotide Sequencing | |
| Risk Assessment | |
| Prognosis |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34,381,934 | TERT Promoter Mutations Are Enriched in Oral Cavity Cancers and Associated With Locoregional Recurrence. | JCO Precis Oncol | 2021 | https://conductscience.org/library/papers/34381934 | PubMed |
| 2 | 24,613,650 | Genomic DNA copy number alterations from precursor oral lesions to oral squamous cell carcinoma. | Oral Oncol | 2014 | https://conductscience.org/library/papers/24613650 | PubMed |
| 3 | 30,513,772 | Distinctive Expression and Amplification of Genes at 11q13 in Relation to HPV Status with Impact on Survival in Head and Neck Cancer Patients. | J Clin Med | 2018 | https://conductscience.org/library/papers/30513772 | PubMed |
| 4 | 3,907,856 | Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. | Cell | 1985 | https://conductscience.org/library/papers/3907856 | PubMed |
| 5 | 39,289,898 | Prognostic impact of caspase-8 mutation in oral cavity squamous cell carcinoma. | Oral Dis | 2025 | https://conductscience.org/library/papers/39289898 | PubMed |
| 6 | 27,693,639 | Integrative genomic and functional analysis of human oral squamous cell carcinoma cell lines reveals synergistic effects of FAT1 and CASP8 inactivation. | Cancer Lett | 2016 | https://conductscience.org/library/papers/27693639 | PubMed |
| 7 | 42,207,998 | Novel Synthetic Lethal Therapeutic Strategies in Precision Oncology. | Am Soc Clin Oncol Educ Book | 2026 | https://conductscience.org/library/papers/42207998 | PubMed |
| 8 | 28,255,664 | Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT. | Acta Neuropathol | 2017 | https://conductscience.org/library/papers/28255664 | PubMed |
| 9 | 26,514,096 | Influence of extracapsular nodal spread extent on prognosis of oral squamous cell carcinoma. | Head Neck | 2016 | https://conductscience.org/library/papers/26514096 | PubMed |
| 10 | 29,955,135 | Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012. | Br J Cancer | 2018 | https://conductscience.org/library/papers/29955135 | PubMed |
1 to 10 of 34
See all 34 referencesCited by0
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
None in this release.
Genes16
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BRCA1 | 672 | PubTator's text mining | https://conductscience.org/library/genes/672 | NCBI Gene |
| CASP8 | 841 | PubTator's text mining | https://conductscience.org/library/genes/841 | NCBI Gene |
| CCND1 | 595 | PubTator's text mining | https://conductscience.org/library/genes/595 | NCBI Gene |
| CD274 | 29,126 | PubTator's text mining | https://conductscience.org/library/genes/29126 | NCBI Gene |
| CDKN2A | 1,029 | PubTator's text mining | https://conductscience.org/library/genes/1029 | NCBI Gene |
| CDKN2B | 1,030 | PubTator's text mining | https://conductscience.org/library/genes/1030 | NCBI Gene |
| FGF19 | 9,965 | PubTator's text mining | https://conductscience.org/library/genes/9965 | NCBI Gene |
| FGF3 | 2,248 | PubTator's text mining | https://conductscience.org/library/genes/2248 | NCBI Gene |
| FGF4 | 2,249 | PubTator's text mining | https://conductscience.org/library/genes/2249 | NCBI Gene |
| HRAS | 3,265 | PubTator's text mining | https://conductscience.org/library/genes/3265 | NCBI Gene |
1 to 10 of 16
See all 16 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42758366
GET https://conductscience.org/api/papers/v1/42758366/references?page=2